Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03589547
Title Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung
Acronym 358
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hina Khan
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Rhode Island Hospital Providence Rhode Island 02903 United States Details
The Miriam Hospital Providence Rhode Island 02906 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field